Characteristics | Values |
---|---|
Tested patients (n) | 82 |
Median age (range) | 58 (21–83) |
Sex, n (%) | |
Male | 42 (51) |
Female | 40 (49) |
WHO 2016 classification, n (%) | |
MDS-SLD | 8 10) |
MDS-RS | 4 (5) |
MDS-MLD | 40 (49) |
MDS-EB-1 | 17 (20) |
MDS-EB-2 | 13 (16) |
IPSS risk groups, n (%) | |
Low | 5 (6) |
Intermediate-1 | 54 (66) |
Lower-risk | 59 (72) |
Intermediate-2 | 20 (24) |
High | 3 (4) |
Higher-risk | 23 (28) |
Karyotypes by IPSS, n (%) | |
Good | 54 (66) |
Intermediate | 15 (18) |
Poor | 13 (16) |